Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma

Fig. 1

CAPZA1 expression is correlated with HCC malignancy. a CAPZA1 immunohistochemistry was performed on 129 HCC samples; CAPZA1expression was scored based on the percentage of tumour cells as described in the Methods. b Lymph node metastases in HCC patients of the CAPZA1 overexpression and underexpression groups; red indicates the occurrence of lymph node metastases, and blue indicates no lymph node metastases. c Vascular invasion in HCC patients of the CAPZA1 overexpression and underexpression groups; red indicates the occurrence of vascular invasion, and blue indicates no vascular invasion. d Extrahepatic metastases in HCC patients of the CAPZA1 overexpression and underexpression groups; red indicates the occurrence of extrahepatic metastases, and blue indicates no extrahepatic metastases. e Postoperative survival times of HCC patients of the CAPZA1 overexpression and underexpression groups were analysed via Kaplan–Meier curves. The mean postoperative survival time of the CAPZA1 overexpression group (40.4 ± 2.9 months) was significantly higher than the underexpression group (14.6 ± 2.0 months; P < 0.01)

Back to article page